# Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer

> **NCT05240508** · — · UNKNOWN · sponsor: **University of Vermont** · enrollment: 600 (estimated)

## Conditions studied

- Venous Thromboembolism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05240508
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2023-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05240508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05240508, "Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05240508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*